Absolutely, but it's not clear to me that fewer resources means less transparency. I think it might mean the opposite.
But specifically, disclosure of clinical study reports—these are things that are provided by the company—if Health Canada is looking at this as something that they have to craft and massage and at the resources that will take, yes, that is scary, and they may never get those resources. But if it's empowered to release information that by definition, under the statute, it already has to have from the manufacturers, then you could have greater transparency, in theory, with fewer resources needed.